Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn. [PDF]
Bhatt AH +3 more
europepmc +3 more sources
Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion. [PDF]
ABO incompatibility and other alloantibodies have emerged as a significant cause of hemolytic disease of fetus and newborn (HDFN), leading to neonatal morbidity and mortality.
Jain A +4 more
europepmc +2 more sources
Hemolytic disease of fetus and newborn due to maternal AlloAnti-S antibody. [PDF]
Hemolytic disease of foetus and newborn (HDFN) is a disease characterized by the destruction of fetal red cells by the maternal antibodies which occurs due to allo immunization in the mother by feto-maternal blood group incompatibility.The antibodies ...
Iyyapan SK +3 more
europepmc +2 more sources
Rhesus-D zygosity and hemolytic disease of fetus and newborn. [PDF]
Alloimmunization against the Rhesus-D (RhD) antigen still remains as a major cause of hemolytic disease of fetus and newborn (HDFN). Determination of paternal RhDzygosity is performed by molecular testing and is valuable for the management of ...
Moghaddam M +3 more
europepmc +2 more sources
Understanding Patient Perspectives and Experiences in Severe Hemolytic Disease of the Fetus and Newborn: Insights from Qualitative Interviews. [PDF]
Objective Maternal red cell alloimmunization is a rare pregnancy condition that can cause hemolytic disease of the fetus and newborn (HDFN), which can be serious and fatal. As subsequent alloimmunized pregnancies carry HDFN risk, families’
Barlassina A +6 more
europepmc +2 more sources
Management of suspected allergy to RhD immunoglobulin in a subsequent pregnancy. [PDF]
Hypersensitivity to RhD immune globulin (RhIG) used to prevent hemolytic disease of the fetus and newborn is rare. We present the management of a patient with a history of reaction to RhIG, including prenatal assessment and postnatal provision of RhIG.
Wong K, Ellis AK, Fung Kee Fung K.
europepmc +2 more sources
Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use
Objectives The objective is to present a pregnancy complication associated with intravenous drug use, namely, that of red blood cell alloimmunization and hemolytic disease of the fetus and newborn.
Kara B. Markham +4 more
doaj +3 more sources
Hemolytic disease of the fetus and newborn—a perspective of immunohematology
Background: Hemolytic disease of the fetus and newborn is a public health problem caused by maternal-fetal incompatibility; no prophylaxis is available for most alloantibodies that induce this disease.
Mirelen Moura de Oliveira Rodrigues +3 more
doaj +3 more sources
Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn. [PDF]
Dziegiel MH +8 more
europepmc +2 more sources
Maternal health, neonatology and perinatology towards a standardized outcome set for clinical trials in Hemolytic Disease of the Fetus and Newborn (HDFN): preliminary findings from two European advisory boards. [PDF]
Hemolytic Disease of the Fetus and Newborn (HDFN) remains a serious perinatal condition worldwide despite major advances in antenatal and postnatal care.
Lopriore E +6 more
europepmc +2 more sources

